University of Wollongong launches $50M commercialisation fund

The University of Wollongong has launched a $50 million commercialisation fund to support the translation of the university's research outputs in materials science, health technology, environmental engineering, and digital platforms into commercial ventures that can be scaled from the Illawarra into national and international markets. The fund — established through a combination of state government co-investment, industry partnership contributions, and the university's own research commercialisation reserves — will provide seed capital, technical support, and mentorship to the UOW research teams whose discoveries have commercial potential that the existing grant-funded research framework cannot efficiently develop into viable commercial products.

UOW Vice-Chancellor Professor Patricia Davidson said the commercialisation fund represented a "step change in the university's approach to translating research impact into economic benefit for the Wollongong region and Australia," noting that UOW researchers had historically been strong in producing high-quality research publications but had underperformed in the commercialisation metrics that research rankings increasingly include alongside publication output.

The fund's priority sectors reflect UOW's distinctive research strengths: the Institute for Superconducting and Electronic Materials — one of the world's leading battery materials research centres — the SMART Infrastructure Facility's transport and logistics research, the Illawarra Health and Medical Research Institute's clinical and health technology work, and the SMART Infrastructure analytics platform that has commercial applications in urban planning, transport modelling, and environmental assessment.

Several UOW researchers have already identified commercial applications from their work that the fund will support, with early-stage investments planned in battery materials technology for grid storage applications, predictive maintenance analytics for heavy industry, and diagnostic tools for early detection of conditions in the aged care population that represent a significant growth market given Australia's ageing demographics.

The fund's governance includes an industry advisory board that includes representation from BlueScope Steel, Transport for NSW, Infigen Energy, and Illawarra Health, reflecting the university's intention to align the commercialisation priorities with the needs of the regional and national industries most likely to be customers for the commercial outputs.

This article was compiled by AI from the sources linked above and screened before publishing. See our editorial standards.